MedPath

To study and comparatively evaluate the ketamine-propofol with fentanyl-propofol combination for procedural sedation and analgesia in patients undergoing laparoscopic tubal ligation and to study which drug combination leads to an earlier recovery and discharge.

Phase 2
Completed
Conditions
surgery under anesthesia
Registration Number
CTRI/2011/06/001850
Lead Sponsor
lady hardinge medical college and S S K Hospital university of delhi
Brief Summary

A randomized control trial of ketamine-propofol and fentanyl-propofol combination for procedural sedation and analgesia in laparoscopic tubal ligation in ASA physical status I patients aged 18-45 years female. primary outcome measures Perioperative Hemodynamic Changes Using Ketamine-Propofol And Fentanyl-Propofol Combination For PSA In Laparoscopic Tubal Ligation. secondary outcome measures Postoperative Recovery And Duration Of Hospital Stay And Comfort And Acceptability In The Two Groups

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Inclusion Criteria- American Society of Anesthesiologist physical status I patients aged 18-45 years female scheduled for laparoscopic tubal ligation.
  • Exclusion Criteria- history of upper respiratory tract infections, asthma, allergy to propofol or ketamine, receiving treatment for psychiatric disease, receiving treatment for neuromuscular disease, seizure disorder, acid reflux, hiatus hernia, severe anemia, gross obesity, hepatic,cardiac or pulmonary disease.
Exclusion Criteria
  • Inclusion Criteria- American Society of Anesthesiologist physical status I patients aged 18-45 years female scheduled for laparoscopic tubal ligation.
  • Exclusion Criteria- history of upper respiratory tract infections, asthma, allergy to propofol or ketamine, receiving treatment for psychiatric disease, receiving treatment for neuromuscular disease, seizure disorder, acid reflux, hiatus hernia, severe anemia, gross obesity, hepatic,cardiac or pulmonary disease.
  • Patients who have history of upper respiratory tract infections, asthma or allergy to propofol or ketamine or receiving treatment for any psychiatric or neuromuscular disease, patients with seizure disorder, acid reflux, hiatus hernia, severe anemia, gross obesity, hepatic, cardiac, or pulmonary diseases will be excluded from this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measures patient recovery time and discharge time using Ketamine-Propofol And Fentanyl-Propofol Combination For PSA In Laparoscopic Tubal Ligation.November 2009 to March 2011
Secondary Outcome Measures
NameTimeMethod
postoperative recovery and duration of hospital stay and comfort and acceptability in the two groupspostoperative recovery and duration of hospital stay and comfort and acceptability in the two groups

Trial Locations

Locations (1)

Lady Hardinge Medical College and Associated Hospital

🇮🇳

Delhi, DELHI, India

Lady Hardinge Medical College and Associated Hospital
🇮🇳Delhi, DELHI, India
Dr Ranju Singh
Principal investigator
9811151285
ranjusingh1503@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.